Terms: = Liver cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551
274 results:
1. Early hematopoietic cell transplantation for familial hemophagocytic lymphohistiocytosis in a regional treatment network in Japan.
Ishimura M; Eguchi K; Sonoda M; Tanaka T; Shiraishi A; Sakai Y; Yasumi T; Miyamoto T; Voskoboinik I; Hashimoto K; Matsumoto S; Ozono S; Moritake H; Takada H; Ohga S
Int J Hematol; 2024 May; 119(5):592-602. PubMed ID: 38507116
[TBL] [Abstract] [Full Text] [Related]
2. Identification of FOXP1 as a favorable prognostic biomarker and tumor suppressor in intrahepatic cholangiocarcinoma.
Tang C; Zhuang H; Tong H; Yu X; Chen J; Wang Q; Ma X; Wang B; Hua Y; Shang C; Tang Z
BMC Cancer; 2024 Jan; 24(1):137. PubMed ID: 38279090
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis.
Li R; Liu X; Huang X; Zhang D; Chen Z; Zhang J; Bai R; Zhang S; Zhao H; Xu Z; Zeng L; Zhuang L; Wen S; Wu S; Li M; Zuo Z; Lin J; Lin D; Zheng J
Gut; 2024 Feb; 73(3):470-484. PubMed ID: 38050068
[TBL] [Abstract] [Full Text] [Related]
4. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract] [Full Text] [Related]
5. Ultrasound-triggered release of miR-199a-3p from liposome nanobubbles for enhanced hepatocellular carcinoma treatment.
Guo X; Lin J; Pan L; He K; Huang Z; Chen J; Lin C; Zeng B; Luo S; Wang M
Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):560-571. PubMed ID: 37850395
[TBL] [Abstract] [Full Text] [Related]
6. Solvatochromic sensors detect proteome aggregation in stressed liver tissues with hepatic cancer and cirrhosis.
Jing B; Li J; Guo K; Zeng L; Sui J; Zhang Z; Wang Z; Jin H; Sun J; Xue Z; Zhao Q; Wan W; Dong X
J Mater Chem B; 2023 Sep; 11(32):7654-7662. PubMed ID: 37464917
[TBL] [Abstract] [Full Text] [Related]
7. Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound.
Huang H; Li CQ; He DN; Ruan SM; Li MD; Cheng MQ; Lu MD; Kuang M; Wang W; Wang Y; Chen LD
Eur Radiol; 2023 Dec; 33(12):9336-9346. PubMed ID: 37405501
[TBL] [Abstract] [Full Text] [Related]
8. Interpersonal Values of Patients Participating in Phase II-III Clinical Trials: Implications for Clinical Trial Representativeness.
Gouveia R; Cruz VT; Antão J; Almeida L
Pharmaceut Med; 2023 Jul; 37(4):319-329. PubMed ID: 37249821
[TBL] [Abstract] [Full Text] [Related]
9. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
[TBL] [Abstract] [Full Text] [Related]
10. Purinergic signaling during Marek's disease in chickens.
Akbar H; Fasick JJ; Ponnuraj N; Jarosinski KW
Sci Rep; 2023 Feb; 13(1):2044. PubMed ID: 36739336
[TBL] [Abstract] [Full Text] [Related]
11. Chemokine CCL5 immune subtypes of human liver cancer with prognostic significance.
Xia Y; Zhou L; Yang HC; Yu CW
Int Immunopharmacol; 2022 Dec; 113(Pt A):109372. PubMed ID: 36332449
[TBL] [Abstract] [Full Text] [Related]
12. [A Case of BRAF V600E-Mutant Colorectal cancer Treated Effectively by Encorafenib, Binimetinib, and Cetuximab Triple Therapy].
Sakamoto S; Tagai N; Shimada M; Kurebayashi H; Sawai K; Morikawa M; Koneri K; Tamaki M; Murakami M; Hirono Y; Goi T
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1145-1147. PubMed ID: 36281614
[TBL] [Abstract] [Full Text] [Related]
13. Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway.
Guo M; Wang W; Bai W; Bai Z; Chen W; Su Y; Wu J
Can J Gastroenterol Hepatol; 2022; 2022():6413783. PubMed ID: 36262827
[TBL] [Abstract] [Full Text] [Related]
14. [Analysis of curative effects of chemoembolization with drug-loaded microspheres of different particle sizes for the treatment of hepatocellular carcinoma].
Li Z; Ye BC; Xie RY; Wang YY; Zhang HT; Hu X; Li Y; Wu PL; Ge P; Yu BL; Wu B
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):612-617. PubMed ID: 36038322
[No Abstract] [Full Text] [Related]
15. Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8
Cheng CC; Ho AS; Peng CL; Chang J; Sie ZL; Wang CL; Chen YL; Chen CY
Int Immunopharmacol; 2022 Nov; 112():109110. PubMed ID: 36037651
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes.
Duan S; Gao J; Lou W; Zhang Y; Deng Y; Wang C; Huang H; Xu H; Guo S; Lai S; Xi F; Li Z; Deng L; Zhong Y
BMC Med Genomics; 2022 Jul; 15(1):166. PubMed ID: 35902905
[TBL] [Abstract] [Full Text] [Related]
17. Sero-reactivity to three distinct regions within the hepatitis C virus alternative reading frame protein (ARFP/core+1) in patients with chronic HCV genotype-3 infection.
Elsheikh MEA; McClure CP; Tarr AW; Irving WL
J Gen Virol; 2022 Mar; 103(3):. PubMed ID: 35230930
[TBL] [Abstract] [Full Text] [Related]
18. Personalized functional profiling using
Kim H; El-Khoury V; Schulte N; Zhan T; Betge J; Cousin L; Felli E; Pessaux P; Ogier A; Opitz O; Ku B; Ebert MP; Kwon YJ
Cancer Biol Ther; 2022 Dec; 23(1):96-102. PubMed ID: 35193475
[TBL] [Abstract] [Full Text] [Related]
19. Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease.
Yi M; Feng X; Peng W; Teng F; Tang Y; Chen Z
Eur J Clin Pharmacol; 2022 Apr; 78(4):647-656. PubMed ID: 35032181
[TBL] [Abstract] [Full Text] [Related]
20. Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV-related hepatocellular carcinoma in Egyptians.
Motawi TMK; Sabry D; Shehata NI; William MM; Fahim AT
J Biochem Mol Toxicol; 2022 Mar; 36(3):e22965. PubMed ID: 34783112
[TBL] [Abstract] [Full Text] [Related]
[Next]
